← All stocks

MANNKIND CORP

MNKD Scheduled selling only

CIK 0000899460 #2314 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$127.86K

$127.86K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$127.86K

$0.00 against sales at will

By person

13 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Binder Steven B.

Director

—

$127.86K (1) scheduled

−$127.86K

752,309

0.2340%

$2.87M

−30.0%

Castagna Michael

Chief Executive Officer

—

2,433,779

0.7569%

$9.27M

+10.4%

Tross Stuart A

Chief People & Workpl Officer

—

1,058,142

0.3291%

$4.03M

+2.6%

Thomson David

EVP Genl Counsel & Secretary

—

797,554

0.2480%

$3.04M

−3.9%

Singh Sanjay R

EVP Technical Operations

—

478,966

0.1490%

$1.82M

+18.4%

BLANK BURKHARD

EVP Chief Medical Officer

—

460,791

0.1433%

$1.76M

−5.2%

Sabella Lauren M

EVP Operations

—

349,841

0.1088%

$1.33M

−7.5%

Marasco Dominic

Pres, Endocrine Business Unit

—

343,398

0.1068%

$1.31M

+6,610%

Prentiss Christopher B

Chief Financial Officer

—

318,668

0.0991%

$1.21M

+32.4%

Ahuja Ajay

Chief Medical Officer

—

318,200

0.0990%

$1.21M

—

HOOPER ANTHONY C

Director

—

236,153

0.0734%

$899.74K

+34.1%

Consiglio Ronald J

Director

—

132,342

0.0412%

$504.22K

+8.2%

Shannon James Samuel

Director

—

64,635

0.0201%

$246.26K

+22.8%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 31 Aug 2016